Shares Magazine
374.30p-0.50 (-0.13%)29 Nov 2024, 17:15
Jump to:
Haleon PLC Fundamentals
| Company Name | Haleon PLC | Last Updated | 2024-11-29 |
|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
| Shares in Issue | 9.043 bn | Market Cap | £33.85 bn |
| PE Ratio | 28.36 | Dividend per Share | £0.04 |
| Dividend Yield | 1.66 | Dividend Cover | 2.69 |
| EPS | £0.11 | EPS Growth (%) | 0.05 |
| PEG | 1.70 | DPS Growth (%) | 0 |
| Debt Ratio | 0.2652 | Debt Equity Ratio | 0.4462 |
| Asset Equity Ratio | 1.9989 | Cash Equity Ratio | 0.0318 |
| Quick Ratio | 0.4742 | Current Ratio | 0.84 |
| Price To Book Value | 2.0392 | ROCE | 0 |
Haleon PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Interim | 2024-08-15 | 2024-09-19 | GBP | 0.0200 | |
| Prelim | 2024-03-14 | 2024-05-16 | GBP | 0.0420 | |
| Interim | 2023-08-24 | 2023-10-05 | GBP | 0.0180 | |
| Prelim | 2023-03-16 | 2023-04-27 | GBP | 0.0240 |
Haleon PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £1.90 bn | £1.90 bn | £1.66 bn |
| Intangible Assets | £26.86 bn | £28.44 bn | £27.20 bn |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | £29.24 bn | £30.76 bn | £29.20 bn |
| Stocks | £1.41 bn | £1.35 bn | £951.00 m |
| Debtors | £1.86 bn | £1.88 bn | £3.71 bn |
| Cash & Equivalents | £994.00 m | £606.00 m | £347.00 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £34.05 bn | £34.81 bn | £34.45 bn |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £4.64 bn | £4.37 bn | £4.24 bn |
| Creditors after 1 year | £12.69 bn | £13.99 bn | £3.73 bn |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £17.33 bn | £18.36 bn | £7.97 bn |
| Net assets | £16.73 bn | £16.46 bn | £26.48 bn |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £92.00 m | £92.00 m | £1.00 m |
| Share Premium | 0 | 0 | 0 |
| Profit / Loss | £1.63 bn | £1.62 bn | £1.64 bn |
| Other Equity | £16.61 bn | £16.33 bn | £26.36 bn |
| Preference & Minorities | £123.00 m | £126.00 m | £125.00 m |
| Total Capital Employed | £16.73 bn | £16.46 bn | £26.48 bn |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | £0.35 | £0.38 | £0.00 |
| Debt-to-Equity | £0.53 | £0.61 | £0.00 |
| Assets / Equity | 1.9989 | 1.9989 | 1.9989 |
| Cash / Equity | 0.0318 | 0.0318 | 0.0318 |
| EPS | £0.12 | £0.11 | £0.15 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | £2.10 bn | £2.06 bn | £1.36 bn |
| Cashflow before financing | £532.00 m | £8.97 bn | £120.00 m |
| Increase in Cash | £398.00 m | £190.00 m | £87.00 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £11.30 bn | £10.86 bn | £9.54 bn |
| Cost of sales | £4.55 bn | £4.28 bn | £3.60 bn |
| Gross Profit | £6.75 bn | £6.58 bn | £5.95 bn |
| Operating Profit | £2.00 bn | 0 | 0 |
| Pre-Tax profit | £1.63 bn | £1.62 bn | £1.64 bn |
Haleon PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition. |
| Latest Interim Date | 8 Jul 2024 |
| Latest Fiscal Year End Date | 29 Feb 2024 |
Haleon PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-11-08 | Mr. Alan James Stewart | Non-Executive Director |
| 2023-12-19 | Mr. Manvinder Singh Banga | Non-Executive Director,Senior Independent Non-Executive Director |
| 2024-09-27 | Mr. Brian James McNamara | Executive Director,Chief Executive Officer |
| 2024-11-22 | Ms. Dawn Allen | |
| 2024-09-27 | Mr. Tobias Hestler | Executive Director,Chief Financial Officer |
Haleon PLC Contact Details
| Company Name | Haleon PLC |
|---|---|
| Address | 980 Great West Road, Brentford, TW8 9GS |
| Telephone | +44 2080475000 |
| Website | https://www.haleon.com |
Haleon PLC Advisors
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Anglo American PLC | 2,520.50 | 5.42 |
| Dr. Martens PLC | 69.00 | 5.10 |
| Direct Line Insurance Group PLC | 234.80 | 4.63 |
| Imi PLC | 1,820.00 | 3.29 |
| Raspberry Pi Holdings PLC | 363.80 | 3.00 |
| Dowlais Group PLC | 59.20 | 2.96 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Bank Of Georgia Group PLC | 4,685.00 | -6.21 |
| Tbc Bank Group PLC | 3,030.00 | -5.90 |
| Bae Systems PLC | 1,227.00 | -4.88 |
| W.A.G Payment Solutions PLC | 81.00 | -3.57 |
| Qinetiq Group PLC | 415.20 | -3.49 |
| Nextenergy Solar Fund Limited | 69.10 | -2.68 |
Risers/fallers data from previous trading day.